Training Program in Tuberculosis and HIV Research in Ghana
加纳结核病和艾滋病毒研究培训计划
基本信息
- 批准号:9324379
- 负责人:
- 金额:$ 29.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-01 至 2020-05-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAreaBasic ScienceBehavioral SciencesCaringCause of DeathCessation of lifeClinical SciencesCommunitiesCountryDetectionDisciplineDoctor of PhilosophyEducational workshopEpidemiologyFundingGhanaGoalsGrantHIVHealth ServicesHealth Services ResearchHealth systemHumanInterdisciplinary StudyInterventionMaster&aposs DegreeMentorsMorbidity - disease rateMultidrug-Resistant TuberculosisPersonsPostdoctoral FellowPreventionPublic HealthPublicationsResearchResearch PersonnelResearch PriorityResearch TrainingServicesSocial SciencesSouth AfricaTechnical ExpertiseTrainingTraining ProgramsTuberculosisUSAIDUnited States National Institutes of HealthUniversitiesWorkacademic programco-infectioneffective therapyimplementation scienceinstitutional capacitymeetingsmortalitynovel diagnosticspost-doctoral trainingprograms
项目摘要
DESCRIPTION (provided by applicant): Tuberculosis (TB) is a major cause of morbidity and mortality among people living with human immunodeficiency virus (PLHIV) in Ghana. Despite the availability of effective treatment, TB is the leading cause of death in PLHIV. Over 50% of all
HIV deaths in Ghana are attributed to TB. Consequently, TB in PLHIV is a key priority for both the National TB Control Programme (NTP) and National AIDS Control Programme (NACP). The gaps in TB and HIV research in Ghana cross several disciplines including epidemiology, basic, clinical, social, behavioral, and implementation sciences, as well public health including health systems and health services research. Thus, a multidisciplinary research program is necessary to address yet unanswered and emerging questions that could transform TB prevention and care programs. At a planning meeting in Ghana to develop this application, academics, program managers and community stakeholders identified limited human and institutional research capacity as key barriers to address challenges in areas such as: TB prevention, case detection (including multi-drug resistant TB), integration of TB and HIV services, programmatic rollout of new diagnostics and interventions, as well as health services strengthening including financing. This proposal builds on 10 years of collaborative research between Brown and University of Ghana that led to NIH and USAID grant funding, as well as important publications in the field. The long-term goal of this application is to strengthen institutional capacity at the University of
Ghana for multidisciplinary research with a focus on addressing TB/HIV research priorities. This goal will be achieved through a mix of research training programs in key disciplines. The specific objectives of the program are: (1) To implement a long-term research training program that will lead to a critical mass of researchers in the focus area of TB/HIV coinfection. Degree and post-doctoral training depending on the needs of the trainee will be undertaken at University of Ghana, Brown or at selected Universities in South Africa. (2) To promote and implement mentored research in basic, clinical, social, and implementation sciences, as well as health services research with a focus on TB/HIV priorities in Ghana. (3) Implement medium-term training to gain key technical expertise, as well as in-country short-term research training workshops in partnership with NTP and NACP leading to enhanced care of persons with TB/HIV coinfection. At the end of the 5-year training period, we expect to train PhD and Masters Degree candidates, postdoctoral fellow and short-term trainees with complimentary expertise who will develop and implement independent high-quality research relevant to TB and HIV control in Ghana. Ultimately, the work of trainees and their research collaborators will establish a center of
excellence for TB/HIV research at the University of Ghana.
描述(由申请人提供):结核病(TB)是加纳人类免疫缺陷病毒(PLHIV)感染者发病和死亡的主要原因。尽管有有效的治疗方法,但结核病是艾滋病毒感染者死亡的主要原因。超过50%的
加纳的艾滋病毒死亡归因于结核病。因此,艾滋病毒感染者的结核病是国家结核病控制规划和国家艾滋病控制规划的一个关键优先事项。加纳结核病和艾滋病毒研究的差距跨越几个学科,包括流行病学,基础,临床,社会,行为和实施科学,以及公共卫生,包括卫生系统和卫生服务研究。因此,一个多学科的研究计划是必要的,以解决尚未回答和新出现的问题,可以改变结核病预防和护理计划。在加纳举行的开发该应用程序的规划会议上,学者、项目管理人员和社区利益攸关方将有限的人力和机构研究能力确定为应对以下领域挑战的主要障碍:结核病预防、病例检测(包括耐多药结核病)、结核病和艾滋病毒服务的整合、新诊断和干预措施的方案推出,以及包括融资在内的卫生服务加强。该提案建立在布朗大学和加纳大学之间长达10年的合作研究基础上,该研究为NIH和USAID提供了资助,并在该领域发表了重要出版物。这项申请的长期目标是加强联合国大学的机构能力,
加纳的多学科研究,重点是解决结核病/艾滋病毒研究的优先事项。这一目标将通过关键学科的研究培训计划来实现。该方案的具体目标是:(1)实施一项长期的研究培训方案,使结核病/艾滋病毒合并感染重点领域的研究人员达到临界质量。学位和博士后培训取决于受训者的需要,将在加纳大学布朗分校或南非选定的大学进行。(2)促进和实施基础、临床、社会和实施科学方面的指导研究,以及卫生服务研究,重点是加纳的结核病/艾滋病毒优先事项。(3)实施中期培训,以获得关键的技术专门知识,并与国家结核控制规划和国家艾滋病控制方案合作,在国内举办短期研究培训讲习班,以加强对结核病/艾滋病毒合并感染者的护理。在5年培训期结束时,我们预计将培训博士和硕士学位候选人,博士后研究员和短期学员,他们将开发和实施与加纳结核病和艾滋病毒控制相关的独立高质量研究。最终,学员及其研究合作者的工作将建立一个中心,
加纳大学结核病/艾滋病研究的卓越成就。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Awewura Jacob Kwara其他文献
Awewura Jacob Kwara的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Awewura Jacob Kwara', 18)}}的其他基金
Pharmacokinetics and Pharmacodynamics of Dolutegravir in Children Weighing ≥20 Kg Living with HIV with and without TB Coinfection
多替拉韦在体重≤20公斤的HIV感染者合并或未合并结核感染的儿童中的药代动力学和药效学
- 批准号:
10175510 - 财政年份:2020
- 资助金额:
$ 29.84万 - 项目类别:
Pharmacokinetics and Pharmacodynamics of Dolutegravir in Children Weighing ≥20 Kg Living with HIV with and without TB Coinfection
多替拉韦在体重≤20公斤的HIV感染者合并或未合并结核感染的儿童中的药代动力学和药效学
- 批准号:
10311554 - 财政年份:2020
- 资助金额:
$ 29.84万 - 项目类别:
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
儿童抗结核和抗逆转录病毒药物的药代动力学
- 批准号:
10470380 - 财政年份:2012
- 资助金额:
$ 29.84万 - 项目类别:
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
儿童抗结核和抗逆转录病毒药物的药代动力学
- 批准号:
9052788 - 财政年份:2012
- 资助金额:
$ 29.84万 - 项目类别:
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
儿童抗结核和抗逆转录病毒药物的药代动力学
- 批准号:
8402238 - 财政年份:2012
- 资助金额:
$ 29.84万 - 项目类别:
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
儿童抗结核和抗逆转录病毒药物的药代动力学
- 批准号:
8658450 - 财政年份:2012
- 资助金额:
$ 29.84万 - 项目类别:
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
儿童抗结核和抗逆转录病毒药物的药代动力学
- 批准号:
9769798 - 财政年份:2012
- 资助金额:
$ 29.84万 - 项目类别:
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
儿童抗结核和抗逆转录病毒药物的药代动力学
- 批准号:
10241940 - 财政年份:2012
- 资助金额:
$ 29.84万 - 项目类别:
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
儿童抗结核和抗逆转录病毒药物的药代动力学
- 批准号:
8508996 - 财政年份:2012
- 资助金额:
$ 29.84万 - 项目类别:
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
儿童抗结核和抗逆转录病毒药物的药代动力学
- 批准号:
9319908 - 财政年份:2012
- 资助金额:
$ 29.84万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 29.84万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 29.84万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 29.84万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 29.84万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 29.84万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 29.84万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 29.84万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 29.84万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 29.84万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 29.84万 - 项目类别:
Research Grant